In vitro phosphorylation of BRCA2 by the checkpoint kinase CHEK2.
Germline mutations in both BRCA2 and CHEK2 are associated with an increased risk for male breast cancer. To search for potential interactions between the products of these breast cancer susceptibility genes, we undertook systematic mapping of BRCA2 for potential phosphorylation sites by CHEK2. In vitro kinase assays and mass spectrometric analysis identified a 50 amino-acid fragment within the N-terminus of BRCA2 potentially targeted by CHEK2, containing two major phosphopeptides. Inducible overexpression of this peptide, but not a derivative with mutated phosphorylation sites, leads to increased chromosome fragmentation and suppression of cellular proliferation. These results suggest a link between CHEK2 and BRCA2 pathways, which may contribute to the spectrum of cancers associated with germline CHEK2 mutations.
Kim
S
S
Massachusetts General Hospital Cancer Center, Harvard Medical School, Massachusetts General Hospital, Charlestown, MA 02129, USA.
Mohapatra
G
G
Haber
D A
DA
D000595:Amino Acid Sequence; D024682:BRCA2 Protein / Q000235:genetics / Q000378:metabolism*; D018567:Breast Neoplasms, Male / Q000235:genetics / Q000378:metabolism; D002460:Cell Line; D064447:Checkpoint Kinase 2; D053938:DNA Fragmentation; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D015151:Immunoblotting; D066298:In Vitro Techniques; D008297:Male; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D010766:Phosphorylation; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism*
D024682:BRCA2 Protein; D064447:Checkpoint Kinase 2; C578634:CHEK2 protein, human; D017346:Protein Serine-Threonine Kinases
Science. 1999 Dec 24;286(5449):2528-31
10617473
Nature. 2005 Mar 31;434(7033):598-604
15800615
Cancer Res. 1998 Apr 1;58(7):1367-71
9537231
Genes Dev. 2004 May 15;18(10):1144-53
15131084
Oncogene. 2004 Jan 29;23(4):865-72
14647413
Nat Rev Mol Cell Biol. 2001 Dec;2(12):877-86
11733767
Science. 2000 May 26;288(5470):1425-9
10827953
Science. 1996 Jan 19;271(5247):357-60
8553072
Science. 1998 Dec 4;282(5395):1893-7
9836640
Nature. 2000 Nov 23;408(6811):433-9
11100718
Br J Cancer. 2001 Jul 20;85(2):209-12
11461078
Science. 2000 Mar 10;287(5459):1824-7
10710310
Genes Dev. 2000 Feb 1;14(3):278-88
10673500
Nature. 2000 Mar 9;404(6774):201-4
10724175
EMBO J. 2002 Oct 1;21(19):5195-205
12356735
Prenat Diagn. 2004 Jun;24(6):414-7
15229838
Nat Genet. 1996 May;13(1):123-5
8673091
Br J Cancer. 2003 Nov 17;89(10):1966-70
14612911
Cell. 2002 Jan 25;108(2):171-82
11832208
J Microsc. 2001 Jun;202(Pt 3):464-7
11422667
J Biol Chem. 1999 Nov 12;274(46):32931-5
10551859
Science. 1997 Sep 5;277(5331):1497-501
9278511
Cancer Res. 2004 Apr 15;64(8):2677-9
15087378
DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1039-47
15279791
Mol Cell Biol. 2002 Sep;22(18):6521-32
12192050
Genes Dev. 2000 Feb 1;14(3):289-300
10673501
J Biol Chem. 2003 Sep 19;278(38):35979-87
12815053
Nat Genet. 2002 May;31(1):55-9
11967536
Mol Cell. 1998 Feb;1(3):347-57
9660919
Science. 1997 Sep 5;277(5331):1501-5
9278512
Nature. 2001 Apr 12;410(6830):842-7
11298456
Cold Spring Harb Symp Quant Biol. 2000;65:353-9
12760050